Navigation Links
URAC Showcases Performance Measures for Pharmacy Benefit and Drug Therapy Management Programs
Date:2/17/2010

Accreditation Organization to Present Medication Metrics Workshop at Pharmacy Benefit Management Institute Conference

WASHINGTON, Feb. 17 /PRNewswire-USNewswire/ -- URAC, the nation's leading health care accreditation and education organization, will conduct a workshop on "Medication Adherence and Medication Possession Ratio as a Critical Metric" at the 15th Annual Pharmacy Benefit Management Institute (PBMI) Conference in Phoenix, Ariz. The session will highlight the organization's revised Performance Measurement Reporting Standards for its Pharmacy Benefit Management (PBM) and Drug Therapy Management (DTM) Accreditation programs.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030501/URACLOGO)

"The addition of new measures to our pharmacy programs augments the powerful advantage of URAC accreditation by allowing organizations to demonstrate quantitative results to employers and other purchasers," said Alan P. Spielman, president and CEO of URAC. "Our reporting standards give purchasers a way to objectively compare and evaluate pharmacy management services in terms of consumer engagement, cost effectiveness, and consumer and client satisfaction."

To provide more information on the Medication Possession Ratio measure, Lynn Martin, PhD, RPh, Director of Research Services for URAC, and Terri Smith Moore, PhD, MBA, RPh, Pharmacy Accreditation Reviewer for URAC, will lead a workshop on February 17 at the PBMI Conference to address multiple aspects of medication adherence. John Jones, RPh, JD, senior vice president of professional practice and pharmacy policy at Prescription Solutions and chairman of URAC's Pharmacy Accreditation Advisory Group, will also offer insights on how to apply the revised standards in a real world setting, including how plan sponsors can work with pharmacy benefit managers to improve medication adherence.

"Providing measurement and accountability is important to vendors, consumers, and purchasers alike," said Mr. Jones. "Ultimately, these new performance measures will allow purchasers to make objective comparisons across organizations when they are evaluating pharmacy services vendors. They allow the PBM industry to show transparency to regulators and purchasers, which is important to build public trust."

URAC's path for developing mandatory performance measures is a multi-year, three phase approach. First, organizations report mandatory measures to URAC, placing a particular focus on internal performance improvement and oversight activities. Phase two requires those measures to be externally audited or verified, and URAC then makes composite measurement data available to participating organizations and interested third parties. In the last phase, URAC publishes the detailed public reports on its website with specific information by organization. In addition to its PBM and DTC programs, URAC is adding performance measures to several other programs.

To register for URAC's Medication Possession Ratio workshop, visit http://www.pbmi.com/conference.asp. The workshop began at 9 a.m. MST on February 17, 2010. For more information on URAC's new Performance Measures, go to http://www.urac.org/pqm/, or visit the URAC booth at the PBMI conference February 17-19, 2010 at The Pointe Hilton Tapatio Cliffs Resort in Phoenix, Ariz.

About URAC

URAC, an independent, nonprofit organization, is well-known as a leader in promoting health care quality through its accreditation, education and measurement programs.  URAC offers a wide range of quality benchmarking programs and services that keep pace with the rapid changes in the health care system, and provide a symbol of excellence for organizations to validate their commitment to quality and accountability.  Through its broad-based governance structure and an inclusive standards development process, URAC ensures that all stakeholders are represented in establishing meaningful quality measures for the entire health care industry.  For more information, visit www.urac.org.

SOURCE URAC

RELATED LINKS
http://www.urac.org

'/>"/>

SOURCE URAC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures
2. ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries
3. Enigma Diagnostics Showcases Its Unique Fully Automated rtPCR Based ML (Mini-Laboratory) Instrument For Point-of-Care Testing at MEDICA 2009 In Dusseldorf, Germany
4. King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use
5. Anti-Aging Expo & Symposium Showcases in Charlotte on March 28th
6. Xoft Showcases Interim Clincal Results for Breast Cancer Product and New Indications for Electronic Brachytherapy(eBx) at Astro Meeting
7. InVitria Showcases Cell Culture Productivity Enhancers at BioProcess International
8. ACORN Showcases Oncology CRO, EDC, PRO and Data Warehouse at 44th Annual DIA Meeting
9. Siemens Showcases Its Most Comprehensive and Advanced Breast Care Portfolio
10. Clinical Study Shows Sustamine(TM) L-Alanyl-L-Glutamine Increases Performance in Endurance, Exercise and Activity
11. The Oclaro Next-Generation Orion Fiber-Coupled Diode Laser Raises the Bar for Performance, Cost and Reliability for Solid State Lasers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... NEW YORK , Feb. 4, 2016   Bernstein ... has been filed in the United States District Court for ... of a class (the "Class") consisting of all persons or ... or the "Company") (NASDAQ: INSY ) from March 3, ... charges Insys and certain of its officers with violations of ...
(Date:2/4/2016)... , Feb. 4, 2016 Wegener Polyangiitis ... Global Markets Direct,s, ,Wegener Polyangiitis - Pipeline Review, ... Polyangiitis,s therapeutic pipeline. This report provides comprehensive ... complete with comparative analysis at various stages, therapeutics ... route of administration (RoA) and molecule type, along ...
(Date:2/4/2016)... Summary Breast cancer, a malignant neoplasm, is the ... in women worldwide, accounting for 16% of all female ... women diagnosed with breast cancer has increased over the ... declined due to earlier diagnosis and better treatment options. ... past four decades, especially with increasing usage of targeted ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... In the fourth ... country gathered at the La Valencia Hotel in San Diego, California to discuss ... named the year’s most outstanding franchise, walking away with the coveted David Wright ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Give ... allow users to search for and donate to Give To Cure’s campaign that is ... app that lets users make and share payments through a smart device. In 2015 ...
(Date:2/5/2016)... , ... February 05, 2016 , ... At its annual ... Patrick McDermott as Chairman of the National Board of Directors. Mr. McDermott succeeds former ... the Board,” stated Leslie A. Chambers , APDA President and CEO. “Pat has ...
(Date:2/5/2016)... ... February 05, 2016 , ... Dr. Ben Amini, a ... is now welcoming orthodontist, Dr. Amanda Cheng, to the practice. With the addition ... health care, including general dentistry, cosmetic treatments, periodontics, implant dentistry , endodontics, ...
(Date:2/5/2016)... ... ... Health and wellness is a topic that should concern all Americans; however, it ... illness. Migraines are a severe form of a headache and often are accompanied by ... pain on their worst enemy, the feeling can last for many hours and be ...
Breaking Medicine News(10 mins):